Came across this article, it seems to have a lower early detection rate compared to the current options (Colonoscopies @ 95%, Cologuard @ 92%, FIT @ 74%)
but who knows, maybe the process can be refined over time
https://www.usatoday.com/story/news...en-through-blood-and-stool-tests/71936543007/
Guardant Health, a Silicon Valley company, has developed a DNA blood test called Shield it says can be prescribed by primary care doctors.
Guardant is seeking approval from the Food and Drug Administration, which has scheduled an advisory committee hearing on March 28.
Last year, Guardant released results from a study of 20,000 adults that showed the Shield test identified 83% of colon cancer cases across all stages of the disease. The study detected all late-stage cancers, while the test detected 55% of stage one cancers and 13% of precancerous polyps and other lesions.